Sleep Drugs
40 FDA-approved drugs
TheraRadar tracks 40 FDA-approved sleep drugs from 34 companies across 4 drug classes, led by Pfizer, with 77 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Sleep.
Sleep Approvals by Year
'15
'16
1
'17
'18
1
'19
2
'20
'21
2
'22
1
'23
'24
'25
'26
Recent Sleep Drug Approvals
LUMRYZ
SODIUM OXYBATE
cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy...
2023-05-01
ALKERMES
TASIMELTEON
TASIMELTEON
Non 24-Hour Sleep-Wake Disorder (Non-24) in adults ( 1 ) 1...
2022-12-12
Teva
MT1MT2
QUVIVIQ
DARIDOREXANT HYDROCHLORIDE
adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenanc...
2022-01-07
IDORSIA
OX1ROX2R
HETLIOZ LQ
TASIMELTEON
Non 24-Hour Sleep-Wake Disorder (Non-24) in adults ( 1 ) 1...
2020-12-01
VANDA PHARMS INC
MT1MT2
XYWAV
CALCIUM OXYBATE
cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy...
2020-07-21
JAZZ
GABA-B
DAYVIGO
LEMBOREXANT
adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenanc...
2019-12-20
EISAI INC
OX1ROX2R
SODIUM OXYBATE
SODIUM OXYBATE
cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy...
2017-01-17
AMNEAL
GABA-B
BELSOMRA
SUVOREXANT
insomnia characterized by difficulties with sleep onset and/or sleep maintenance...
2014-08-13
Merck
OX1ROX2R
HETLIOZ
TASIMELTEON
Non-24 in adults...
2014-01-31
VANDA PHARMS INC
MT1MT2
RAMELTEON
RAMELTEON
insomnia characterized by difficulty with sleep onset...
2013-07-26
Dr. Reddy's
MT1 receptorMT2 receptor
INTERMEZZO
ZOLPIDEM TARTRATE
2011-11-23
PURDUE PHARMA
ESZOPICLONE
ESZOPICLONE
insomnia...
2011-05-23
MACLEODS PHARMS
GABA receptor
SILENOR
DOXEPIN HYDROCHLORIDE
insomnia characterized by difficulty with sleep maintenance...
2010-03-17
CURRAX
H1 receptor
EDLUAR
ZOLPIDEM TARTRATE
the short-term treatment of insomnia characterized by difficulties with sleep initiation [see Clinic...
2009-03-13
Viatris
GABA A receptor
ZOLPIMIST
ZOLPIDEM TARTRATE
2008-12-19
AYTU
ZALEPLON
ZALEPLON
the short-term treatment of insomnia...
2008-06-06
Hikma
TOVALT ODT
ZOLPIDEM TARTRATE
2007-04-25
BIOVAIL LABS INTL
ZOLPIDEM TARTRATE
ZOLPIDEM TARTRATE
2007-04-23
STRIDES PHARMA INTL
AMBIEN CR
ZOLPIDEM TARTRATE
the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep mai...
2005-09-02
COSETTE
GABA A receptor
ROZEREM
RAMELTEON
insomnia characterized by difficulty with sleep onset...
2005-07-22
Takeda
MT1 receptorMT2 receptor
Showing the 20 most recent of 40 sleep drugs. View all 40 →
Top Sleep Companies
Sleep Active Trials by Indication
77 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Sleep Drug Classes
Melatonin Receptor Agonist 5
Benzodiazepine 4
Orexin Receptor Antagonist 3
gamma-Aminobutyric Acid A Receptor Agonist 1
Sleep at a Glance
- Total Drugs
- 40
- Companies
- 34
- Drug Classes
- 4
- Active Trials
- 77
- Latest Approval
- 2023-05-01